Biotech Report: Evotec (EVT) behauptet, MorphoSys (MOR) tiefrot
Biotech-Aktien zeigen sich zum Wochenauftakt überwiegend leichter. Während sich Papiere von Evotec behaupten können, rutschen MorphoSys deutlich ab.…
1.138,810$
-0,69%
Echtzeit-Aktienkurs Regeneron Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie
Regeneron: FDA Grants Pediatric Exclusivity For EYLEA
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the FDA has granted pediatric exclusivity for EYLEA Injection. This extends the…
Regeneron wins six-month pediatric exclusivity for Eylea in U.S. market
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 264.741$
Landry, Robert E. - Vorstand - Tag der Transaktion: 2022-10-17...…
Regeneron Pharmaceuticals: Downgrade
New York (www.aktiencheck.de) - Rating-Update:
Joshua Schimmer, Analyst von Evercore ISI, setzt seine Einschätzung für die Aktie von Regeneron Pharmaceuticals Inc.…
Regeneron (REGN) Stock Sinks As Market Gains: What You Should Know
Regeneron (REGN) closed the most recent trading day at $735.96, moving -0.01% from the previous trading session....…
If You Invested $100 In This Stock 20 Years Ago, You Would Have $5,000 Today
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.25% on an annualized basis producing an…
Regeneron (REGN) Drug Gets Positive CHMP View for Cervical Cancer
Regeneron (REGN) gets a positive recommendation from CHMP for the label expansion of its oncology drug for treating adult patients…
Analyst Ratings for Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings within the last quarter:
Latest Ratings for REGN
…
Biotech Investors Need Patience (And a Strong Stomach)
The sector has been tricky for investors. Regeneron Pharmaceuticals is an example, getting a downgrade to In Line from Outperform…
Regeneron downgraded at Evercore citing eyecare landscape
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Pharma: CHMP Adopts Positive Opinion For Libtayo
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the European Medicines Agencys CHMP has adopted a positive opinion for Libtayo…
Regeneron Gets CHMP Backing for Libtayo for Advanced Cervical Cancer >REGN
Regeneron Gets CHMP Backing for Libtayo for Advanced Cervical Cancer >REGN...…
Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat Advanced Cervical Cancer
Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to…
Regeneron: EYLEA SBLA Gets FDA Priority Review
LEVERKUSEN (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the FDA has accepted for Priority Review the supplemental Biologics License Application…
Sanofi/Regeneron Dupixent shows efficacy in kids with esophagus inflammation in phase 3 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron Reports Positive Results From Dupixent Phase 3 Trial In 1 To 11 Yrs With EoE
PARIS (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY, SNYNF) on Tuesday presented late-breaking positive results from a Phase…
Sanofi and Regeneron present more positive data for Dupixent product
...PARIS (Reuters) - Healthcare companies Sanofi and partner......…
Insiderhandel: SVP Controller verkauft Aktien von Regeneron Pharmaceuticals im Wert von 1.381.156$
Fenimore, Christopher R. - Vorstand - Tag der Transaktion: 2022-10-05...…
Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022
TARRYTOWN, N.Y., Oct. 4, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third…
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Regenerons (REGN) top line is affected by negligible sales from REGEN-COV while lead drug Eylea faces stiff competition....…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.624.685$
Tessier-Lavigne, Marc - Aufsichtsrat - Tag der Transaktion: 2022-09-29...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.392.744$
Tessier-Lavigne, Marc - Aufsichtsrat - Tag der Transaktion: 2022-09-30...…
Regeneron Elects Dr. Craig B. Thompson to Board of Directors
Former President and CEO of Memorial Sloan Kettering Cancer Center brings a unique combination of business and scientific leadership, with…
Antikörper-Mittel von Regeneron senkt Risiko einer Corona-Infektion
Frankfurt (Reuters) - Eine Antikörper-Therapie des US-Pharmakonzerns Regeneron hilft einer Studie zufolge auch bei der Vorbeugung gegen eine symptomatische Covid-19-Infektion.
Regeneron…
Regeneron - Tierstudie zeigt Wirksamkeit von Wirkstoffkombination
(Reuters) - Das US-Biotech-Unternehmen Regeneron Pharmaceuticals hat in einer Studie an Tieren die Wirksamkeit einer Antikörper-Kombination zur Behandlung von Coronavirus-Erkrankungen…